Acetyl-L-carnitine Reduces Depression And Improves Quality Of Life In Patients With Minimal Hepatic Encephalopathy
Notes for this study:
||State Trait Inventory. Mean and SD. Placebo: before 49.2 ± 6.5, after 46.3 ± 6.6. Carnitine: before 49.6 ± 7.6, after 40.5 ± 5.7
|Number of Subjects
Acetyl-L-Carnitine at 4g a day (2g, twice a day) was associated with decreased depression and improved quality of life as a result of hepatic encepalopathy.